Literature DB >> 7369219

Relationship between cimetidine plasma levels and gastric acidity in acutely ill patients.

I A Cohen, J K Siepler, R Nation, C T Bombeck, L M Nyhus.   

Abstract

The relationship between cimetidine plasma levels and gastric acidity was studied in acutely ill patients. Patients in surgical intensive care for stress ulcer who were being managed with nasogastric suction were studied. Nine patients (Group 1) received 300 mg of intravenous cimetidine over 30 minutes every six hours. Titratable acidity and pH of gastric aspirates and plasma cimetidine levels were measured at peak (1.5--2.5 hours) and trough (5--6 hours) times following cimetidine administration, in Group 1. Titratable acidity and pH were measured for nine Group 2 patients (control) who did not receive cimetidine. In Group 1, mean gastric acid output was significantly lower (p less than 0.05) and mean pH was significantly higher (p less than 0.005) than in Group 2. In Group 1, plasma cimetidine concentration correlated poorly with gastric pH and gastric acid output (r = 0.21). The study indicates that the correlation between plasma cimetidine levels and gastric acid secretion is poor, but that the cimetidine dosage used suppressed acid output during the entire dosing interval.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7369219

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  10 in total

1.  Modulation of gastric pH by continuous gastric and jejunal infusion of cimetidine.

Authors:  U K Murthy; W G Linscheer
Journal:  Dig Dis Sci       Date:  1991-02       Impact factor: 3.199

Review 2.  Cimetidine in preventing or treating acute upper gastrointestinal tract hemorrhage.

Authors:  R R Babb
Journal:  West J Med       Date:  1984-03

3.  The kinetics of oral cimetidine in children with cystic fibrosis.

Authors:  R A Bradbear; R W Shepherd; C McGuffie; J Grice; R K Roberts
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

4.  Influence of phenobarbital treatment on cimetidine kinetics.

Authors:  A Somogyi; S Thielscher; R Gugler
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

5.  Reduction of metformin renal tubular secretion by cimetidine in man.

Authors:  A Somogyi; C Stockley; J Keal; P Rolan; F Bochner
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

Review 6.  Clinical pharmacokinetics of cimetidine.

Authors:  A Somogyi; R Gugler
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

7.  Dose and concentration dependent effect of ranitidine on procainamide disposition and renal clearance in man.

Authors:  A Somogyi; F Bochner
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

8.  Pharmacokinetics of cimetidine in critically ill patients.

Authors:  R L Nation; K F Ilett; R Tjokrosetio; T E Oh; P Cameron; W Thompson
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Lack of inhibition of tolbutamide hydroxylation by cimetidine in man.

Authors:  C Stockley; J Keal; P Rolan; F Bochner; A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Lack of effect of cimetidine on the pharmacokinetics of R(-)- and S(+)-ibuprofen.

Authors:  A M Evans; R L Nation; L N Sansom
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.